Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 613 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 101-125 of 205 matching filings.

Per page
25
Current page
5
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
04 May 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Apr 2017
Reporting date
20 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Apr 2017
Reporting date
17 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
17 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
27 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
23 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
16 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
16 Mar 2017
Reporting date
14 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 Mar 2017
Reporting date
14 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
13 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
09 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
09 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
02 Mar 2017
Reporting date
02 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
02 Mar 2017
Reporting date
02 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
01 Mar 2017
Reporting date
01 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
16 Feb 2017
Reporting date
16 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 Feb 2017
Reporting date
14 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
07 Feb 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
26 Jan 2017
Reporting date
26 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
03 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
29 Dec 2016
Reporting date
28 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .